BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11812860)

  • 1. A novel technique for the identification of CpG islands exhibiting altered methylation patterns (ICEAMP).
    Brock GJ; Huang TH; Chen CM; Johnson KJ
    Nucleic Acids Res; 2001 Dec; 29(24):E123. PubMed ID: 11812860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
    Tryndyak V; Kovalchuk O; Pogribny IP
    Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
    Toyota M; Ho C; Ahuja N; Jair KW; Li Q; Ohe-Toyota M; Baylin SB; Issa JP
    Cancer Res; 1999 May; 59(10):2307-12. PubMed ID: 10344734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
    Kao RH; Huang LC; Hsu YH
    Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
    Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
    Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer.
    Rauch T; Pfeifer GP
    Lab Invest; 2005 Sep; 85(9):1172-80. PubMed ID: 16025148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation profiling using the methylated-CpG island recovery assay (MIRA).
    Rauch TA; Pfeifer GP
    Methods; 2010 Nov; 52(3):213-7. PubMed ID: 20304072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
    Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
    Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer.
    Nishiyama R; Qi L; Lacey M; Ehrlich M
    Mol Cancer Res; 2005 Nov; 3(11):617-26. PubMed ID: 16317087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and analysis of sequences showing sex-specific cytosine methylation in the mealybug Planococcus lilacinus.
    Mohan KN; Chandra HS
    Mol Genet Genomics; 2005 Dec; 274(6):557-68. PubMed ID: 16283386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis and modeling of DNA methylation susceptibility in 30 breast cancer cell lines by using CpG flanking sequences.
    An J; Kim K; Rhee SM; Chae H; Nephew KP; Kim S
    J Bioinform Comput Biol; 2013 Jun; 11(3):1341003. PubMed ID: 23796180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation.
    Yegnasubramanian S; Lin X; Haffner MC; DeMarzo AM; Nelson WG
    Nucleic Acids Res; 2006 Feb; 34(3):e19. PubMed ID: 16473842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islands.
    Dai W; Teodoridis JM; Graham J; Zeller C; Huang TH; Yan P; Vass JK; Brown R; Paul J
    BMC Bioinformatics; 2008 Aug; 9():337. PubMed ID: 18691414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Techniques used in studies of age-related DNA methylation changes.
    Wojdacz TK; Hansen LL
    Ann N Y Acad Sci; 2006 May; 1067():479-87. PubMed ID: 16804030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for analysis of specific DNA methylation status.
    Pajares MJ; Palanca-Ballester C; Urtasun R; Alemany-Cosme E; Lahoz A; Sandoval J
    Methods; 2021 Mar; 187():3-12. PubMed ID: 32640317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-specific PCR.
    Ku JL; Jeon YK; Park JG
    Methods Mol Biol; 2011; 791():23-32. PubMed ID: 21913069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction.
    Liang G; Gonzalgo ML; Salem C; Jones PA
    Methods; 2002 Jun; 27(2):150-5. PubMed ID: 12095274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.